Whitehawk Therapeutics, Inc. (WHWK) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$19.2K2011: -$22.8K2012: -$24.5K2013: -$23.3K2014: -$16.0K2015: -$21.7K2016: -$24.5K2017: -$18.88M2018: -$5.81M2019: -$23.85M2020: -$12.70M2021: -$22.42M2022: -$49.64M2023: -$59.66M2024: -$59.55M2025: -$97.43M-$97.43M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$97.43M-63.6%
2024-$59.55M+0.2%
2023-$59.66M-20.2%
2022-$49.64M-121.4%
2021-$22.42M-76.5%
2020-$12.70M+46.8%
2019-$23.85M-310.7%
2018-$5.81M+69.2%
2017-$18.88M-76922.2%
2016-$24.5K-12.8%
2015-$21.7K-35.7%
2014-$16.0K+31.3%
2013-$23.3K+4.9%
2012-$24.5K-7.7%
2011-$22.8K-18.3%
2010-$19.2K